Market Cap (In INR)
45.02 Billion
Revenue (In INR)
8.06 Billion
Net Income (In INR)
861.35 Million
Avg. Volume
11.16 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 278.0-501.1
- PE
- -
- EPS
- -
- Beta Value
- 0.796
- ISIN
- INE742B01025
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Pranav Jayesh Choksi
- Employee Count
- -
- Website
- https://www.gufic.com
- Ipo Date
- 2001-03-05
- Details
- Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. The company manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. It manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, the company offers spark, criti care, criticare life, and ferticare pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India.
More Stocks
-
002790
-
LSPKLifeSpeak Inc.
LSPK
-
AUSTAustin Gold Corp.
AUST
-
AMAT
-
RBLBANKRBL Bank Limited
RBLBANK
-
SLMNSolis Minerals Ltd.
SLMN
-
MKP
-
7155SKP Resources Bhd
7155